Literature DB >> 10975910

Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies.

H Possel1, H Noack, J Putzke, G Wolf, H Sies.   

Abstract

A role for free radicals has been proposed in infectious brain disease, where resident microglia cells upregulate the inducible nitric oxide synthase isoform (iNOS), and thus are capable of producing nitric oxide at enhanced rates. Using the constitutively expressed NADPH oxidase, microglial cells can generate superoxide, which reacts with nitric oxide to form the powerful oxidant peroxynitrite. In a mixed cell culture system of astrocytes and microglial cells, nitrite levels, used as an indicator of nitric oxide production, were elevated after the addition of lipopolysaccharide (LPS) and cytokines. Immunohistochemistry and the NADPH diaphorase technique demonstrated selective localization of the iNOS protein in microglial cells, whereas no iNOS protein or NADPH diaphorase activity was detected in astrocytes. A similar cellular distribution was observed in vivo following injection of LPS and cytokines into the rat striatum. By contrast, LPS and interferon-gamma led to translocation of NF-kappaB in microglia and in astrocytes, demonstrating that both cell types are responsive to the stimulus. Therefore, downstream control in iNOS expression is cell type-specific. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975910     DOI: 10.1002/1098-1136(200010)32:1<51::aid-glia50>3.0.co;2-4

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  51 in total

Review 1.  Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

Authors:  J C Felger; F E Lotrich
Journal:  Neuroscience       Date:  2013-05-03       Impact factor: 3.590

Review 2.  Estrogens, Neuroinflammation, and Neurodegeneration.

Authors:  Alessandro Villa; Elisabetta Vegeto; Angelo Poletti; Adriana Maggi
Journal:  Endocr Rev       Date:  2016-05-19       Impact factor: 19.871

Review 3.  Regulation of inducible nitric oxide synthase gene in glial cells.

Authors:  Ramendra N Saha; Kalipada Pahan
Journal:  Antioxid Redox Signal       Date:  2006 May-Jun       Impact factor: 8.401

Review 4.  Bioenergetic regulation of microglia.

Authors:  Soumitra Ghosh; Erika Castillo; Elma S Frias; Raymond A Swanson
Journal:  Glia       Date:  2017-12-08       Impact factor: 7.452

5.  Immunological aspects in amyotrophic lateral sclerosis.

Authors:  Maria Carolina O Rodrigues; Júlio C Voltarelli; Paul R Sanberg; Cesario V Borlongan; Svitlana Garbuzova-Davis
Journal:  Transl Stroke Res       Date:  2012-05-03       Impact factor: 6.829

6.  Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.

Authors:  Jaewon Lee; Sic L Chan; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

Review 7.  RNA oxidation and zinc in hepatic encephalopathy and hyperammonemia.

Authors:  Freimut Schliess; Boris Görg; Dieter Häussinger
Journal:  Metab Brain Dis       Date:  2009-01-16       Impact factor: 3.584

Review 8.  Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria.

Authors:  Guy C Brown; Anna Bal-Price
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

9.  The potential role of nitric oxide synthase in survival and regeneration of magnocellular neurons of hypothalamo-neurohypophyseal system.

Authors:  Qiuju Yuan; David E Scott; Kwow-Fai So; Zhixiu Lin; Wutian Wu
Journal:  Neurochem Res       Date:  2009-04-21       Impact factor: 3.996

10.  Inducible nitric oxide synthase in neutrophils and endothelium contributes to ischemic brain injury in mice.

Authors:  Lidia Garcia-Bonilla; Jamie M Moore; Gianfranco Racchumi; Ping Zhou; Jason M Butler; Costantino Iadecola; Josef Anrather
Journal:  J Immunol       Date:  2014-07-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.